HIV and mucosal barrier interactions: Consequences for transmission and pathogenesis

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 22-30

  Burgener, Adam ^a,b,c   McGowan, Ian ^d,e   Klatt, Nichole R ^f,g  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Washington National Primate Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; EPITHELIUM; GASTROINTESTINAL MUCOSA; GENITAL SYSTEM; HEALTH STATUS; HOST; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROENVIRONMENT; MICROFLORA; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; MUCUS; NONHUMAN; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; ANIMAL; DISEASE PREDISPOSITION; IMMUNOLOGY; MICROBIOLOGY; MUCOSA; PATHOLOGY; SEXUALLY TRANSMITTED DISEASE; TRANSMISSION; VIROLOGY;

ANIMALS; DISEASE SUSCEPTIBILITY; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; MICROBIOTA; MUCOUS MEMBRANE; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 84934768447     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.06.004     Document Type: Review

References (112)

1. Haase A.T. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011, 62:127-139.
2. Kaul R., Ball T.B., Hirbod T. Defining the genital immune correlates of protection against HIV acquisition: co-infections and other potential confounders. Sex Transm Infect 2011, 87:125-130.
3. Naranbhai V., et al. Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. J Infect Dis 2012, 206:993-1001.
4. Hammer S.M., et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med 2013, 369:2083-2092.
5. Walker B.D., Burton D.R. Toward an AIDS vaccine. Science 2008, 320:760-764.
6. Baggaley R.F., White R.G., Boily M.C. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010, 39:1048-1063.
7. Anderson D.J., Marathe J., Pudney J. The structure of the human vaginal stratum corneum and its role in immune defense. Am J Reprod Immunol 2014, 71:618-623.
8. Venkataraman N., Cole A.L., Svoboda P., Pohl J., Cole A.M. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol 2005, 175:7560-7567.
9. Linden S.K., Sutton P., Karlsson N.G., Korolik V., McGuckin M.A. Mucins in the mucosal barrier to infection. Mucosal Immunol 2008, 1:183-197.
10. Aboud L., Tjernlund A., Ball T.B., Burgener A. The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV. Am J Reprod Immunol 2013, 71:12-23.
11. Silverman G.A., et al. Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems. J Biol Chem 2010, 285:24299-24305.
12. Miller C.J., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005, 79:9217-9227.
13. Shukair S.A., et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 2013, 6:427-434.
14. Carias A.M., et al. Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol 2013, 87:11388-11400.
15. Douek D.C., et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 417:95-98.
16. Carnathan D.G., et al. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques. Proc Natl Acad Sci U S A 2015, 112:518-523.
17. Rodriguez-Garcia M., Barr F.D., Crist S.G., Fahey J.V., Wira C.R. Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tract. Mucosal Immunol 2014, 7:1375-1385.
18. Joag V.R., et al. Identification of preferential CD4 T-cell targets for HIV infection in the cervix. Mucosal Immunol 2015, Advanced online publication.
19. Poles M.A., Elliott J., Taing P., Anton P.A., Chen I.S. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol 2001, 75:8390-8399.
20. Allers K., et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J Infect Dis 2014, 209:739-748.
21. McElrath M.J., et al. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. J Acquir Immune Defic Syndr 2013, 63:263-271.
22. Preza G.C., et al. Antigen-presenting cell candidates for HIV-1 transmission in human distal colonic mucosa defined by CD207 dendritic cells and CD209 macrophages. AIDS Res Hum Retroviruses 2014, 30:241-249.
23. Cavarelli M., Foglieni C., Rescigno M., Scarlatti G. R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5. EMBO Mol Med 2013, 5:776-794.
24. Li Q., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
25. Hirbod T., et al. HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog 2014, 10:e1004416.
26. Levinson P., et al. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009, 23:309-317.
27. Ogawa Y., et al. Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe 2013, 13:77-86.
28. Yang D., Chertov O., Oppenheim J.J. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 2001, 69:691-697.
29. Mlisana K., et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012, 206:6-14.
30. Masson L., et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis 2015.
31. Arnold K., et al. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV susceptible target cells. Mucosal Immunol 2015, in press.
32. Card C.M., Ball T.B., Fowke K.R. Immune quiescence: a model of protection against HIV infection. Retrovirology 2013, 10:141.
33. McLaren P.J., et al. HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 2010, 202(Suppl 3):S339-S344.
34. Lajoie J., et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol 2012, 5:277-287.
35. Burgener A., et al. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res 2011, 10:5139-5149.
36. Burgener A., et al. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res 2008, 7:4446-4454.
37. Iqbal S.M., et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 2009, 23:1669-1677.
38. Pott G.B., Chan E.D., Dinarello C.A., Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009, 85:886-895.
39. Ashton-Rickardt P.G. Serine protease inhibitors and cytotoxic T lymphocytes. Immunol Rev 2010, 235:147-158.
40. Benarafa C., Priebe G.P., Remold-O'Donnell E. The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J Exp Med 2007, 204:1901-1909.
41. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013, 13:159-175.
42. Zhao P., Hou L., Farley K., Sundrud M.S., Remold-O'Donnell E. SerpinB1 regulates homeostatic expansion of IL-17+ gammadelta and CD4+ Th17 cells. J Leukoc Biol 2014, 95:521-530.
43. McKinnon L.R., et al. Early HIV-1 infection is associated with reduced frequencies of cervical Th17 cells. J Acquir Immune Defic Syndr 2015, 68:6-12.
44. Munch J., et al. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 2007, 129:263-275.
45. Ghosh M., et al. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2009, 129:207-219.
46. Whitney J.B., Asmal M., Geiben-Lynn R. Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication. PLoS One 2011, 6:e18589.
47. Southern P.J. Missing out on the biology of heterosexual HIV-1 transmission. Trends Microbiol 2013, 21:245-252.
48. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66:1-9.
49. Maslinska D., Gajewski M. Some aspects of the inflammatory process. Folia neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Pol Acad Sci 1998, 36:199-204.
50. Punchard N.A., Whelan C.J., Adcock I. The Journal of Inflammation. J Inflamm 2004, 1:1.
51. Wilgus T.A., Roy S., McDaniel J.C. Neutrophils and wound repair: positive actions and negative reactions. Adv Wound Care 2013, 2:379-388.
52. Mackelprang R.D., et al. Genital proteome correlates of highly HIV-1 exposed uninfected African women. AIDS Res Hum Retroviruses 2014, 30(Suppl 1):A82.
53. Lai S.K., et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009, 83:11196-11200.
54. Sharkey D.J., Tremellen K.P., Jasper M.J., Gemzell-Danielsson K., Robertson S.A. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012, 188:2445-2454.
55. Prakash M., Patterson S., Gotch F., Kapembwa M.S. Recruitment of CD4 T lymphocytes and macrophages into the cervical epithelium of women after coitus. Am J Obst Gynecol 2003, 188:376-381.
56. Lajoie J., et al. Association of sex work with reduced activation of the mucosal immune system. J Infect Dis 2014, 210:319-329.
57. Heffron R., et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012, 12:19-26.
58. Morrison C.S., et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med 2015, 12:e1001778.
59. Wira C.R., Fahey J.V. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008, 22:1909-1917.
60. Kersh E.N., et al. SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol 2014, 43:310-316.
61. Vishwanathan S.A., et al. High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 2011, 57:261-264.
62. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998, 14(Suppl 1):S119-S123.
63. Saba E., et al. Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol 2013, 6:1081-1090.
64. Birse K., et al. Molecular signatures of immune activation and epithelial barrier remodeling are enhanced during the luteal phase of the menstrual cycle: implications for HIV susceptibility. J Virol 2014, Advanced online publication.
65. Freeman E.E., et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73-83.
66. Houlihan C.F., et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS 2012, 26:2211-2222.
67. Kaul R., et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008, 77:32-40.
68. Rebbapragada A., et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007, 21:589-598.
69. Zhu J., et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009, 15:886-892.
70. Martinelli E., et al. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog 2011, 7:e1002109.
71. Rollenhagen C., Lathrop M.J., Macura S.L., Doncel G.F., Asin S.N. Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides. Mucosal Immunol 2014, 7:1165-1174.
72. Scott M., Stites D.P., Moscicki A.B. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol 1999, 6:751-755.
73. Bissessor M., et al. The etiology of infectious proctitis in men who have sex with men differs according to HIV status. Sex Transm Dis 2013, 40:768-770.
74. Hoentjen F., Rubin D.T. Infectious proctitis: when to suspect it is not inflammatory bowel disease. Dig Dis Sci 2012, 57:269-273.
75. Marcus U., et al. Risk factors for HIV and STI diagnosis in a community-based HIV/STI testing and counselling site for men having sex with men (MSM) in a large German city in 2011-2012. BMC Infect Dis 2015, 15:14.
76. Welling C.A., et al. Association of HIV infection with anal and penile low-risk human papillomavirus infections among men who have sex with men in Amsterdam: the HIV & HPV in MSM study. Sex Transm Dis 2015, 42:297-304.
77. Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008, 22:1493-1501.
78. Mirmonsef P., Krass L., Landay A., Spear G.T. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res 2012, 10:202-210.
79. Schellenberg J.J., et al. Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis. AIDS 2012, 26:387-393.
80. Borgdorff H., et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J 2014, 8:1781-1793.
81. Srinivasan S., et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 2012, 7:e37818.
82. Marconi C., et al. Cervicovaginal levels of proinflammatory cytokines are increased during chlamydial infection in bacterial vaginosis but not in lactobacilli-dominated flora. J Low Genit Tract Dis 2014, 18:261-265.
83. Masson L., et al. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect 2014, 90:580-587.
84. Sycuro L.K., Gorgos L.M., Fiedler T.L., Srinivasan S., Marrazzo J.M., Fredricks D.N. Association of Mageebacillus indolicus (BVAB-3) with cervicitis suggests teh virulence potential of this novel vaginal bacterium. Am Soc Microbiol 2012, Abstract.
85. Rebbapragada A., et al. Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008, 49:520-522.
86. Arnold K., et al. Mucosal integrity factors are perturbed during bacterial vaginosis: a proteomic analysis. AIDS Res Hum Retroviruses 2014, 30:A30.
87. Kalinin A.E., Kajava A.V., Steinert P.M. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002, 24:789-800.
88. Dinh M.H., McRaven M.D., Kelley Z., Penugonda S., Hope T.J. Keratinization of the adult male foreskin and implications for male circumcision. AIDS 2010, 24:899-906.
89. Anahtar M.N., et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 2015, 42:965-976.
90. Yu G., Fadrosh D., Ma B., Ravel J., Goedert J.J. Anal microbiota profiles in HIV-positive and HIV-negative MSM. AIDS 2014, 28:753-760.
91. Vujkovic-Cvijin I., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013, 5:193ra191.
92. Brenchley J.M., Price D.A., Douek D.C. HIV disease: fallout from a mucosal catastrophe?. Nat Immunol 2006, 7:235-239.
93. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
94. Estes J.D., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010, 6:e1001052.
95. Nazli A., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010, 6:e1000852.
96. Hunt P.W., et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis 2014.
97. Canary L.A., et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol 2013, 190:2959-2965.
98. Schuetz A., et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 2014, 10:e1004543.
99. Klatt N.R., et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 2012, 5:646-657.
100. Klatt N.R., Brenchley J.M. Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 2010, 5:135-140.
101. Brenchley J.M., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112:2826-2835.
102. Lederman M.M., Funderburg N.T., Sekaly R.P., Klatt N.R., Hunt P.W. Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol 2013, 119:51-83.
103. Klatt N.R., Chomont N., Douek D.C., Deeks S.G. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev 2013, 254:326-342.
104. Doitsh G., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014, 505:509-514.
105. Favre D., et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010, 2:32ra36.
106. Serrano-Villar S., et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014, 10:e1004078.
107. Somsouk M., et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 2015, 29:43-51.
108. Dillon S.M., et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 2014, 7:983-994.
109. Dillon S.M., et al. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T cell activation in untreated HIV-1 infection. Mucosal Immunol 2015, (in press, advanced online publication).
110. Klase Z., et al. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol 2015, Advanced online publication.
111. Barrenas F., et al. Deep transcriptional sequencing of mucosal challenge compartment from rhesus macaques acutely infected with simian immunodeficiency virus implicates loss of cell adhesion preceding immune activation. J Virol 2014, 88:7962-7972.
112. Mohan M., et al. Focused examination of the intestinal epithelium reveals transcriptional signatures consistent with disturbances in enterocyte maturation and differentiation during the course of SIV infection. PLoS One 2013, 8:e60122.